Preliminary guidelines for the off-label use of calcium hydroxylapatite (CaHA) for biostimulation in the face and body has been published in Dermatologic Surgery.
The US Food and Drug Administration (FDA) has approved hyaluronic acid dermal filler Restylane Lyft for cheek augmentation and the correction of age-related mid-face contour deficiencies via small blunt tip cannula in patients over the age of 21.
A pharmacy that is ‘dedicated to private prescribers’ called Galenic Laboratories, trading as Roseway Labs, has launched into the aesthetic sector.
UK distributor Healthxchange Pharmacy has launched two Obagi Men kits. The kits, called ‘Leather’, which is more suited to normal/dry skin, and ‘Steel’, for normal/oily skin, aim to target ageing, provide hydration and to give protection, the company claims.
Dr Patrick Treacy has opened a new clinic called Ailesbury Lite in Cork, Ireland, to offer a number of aesthetic treatments including injectables, skin rejuvenation and body contouring.
Skin checking app Miiskin has become the first app to receive accreditation from global independent dermatological accreditor, Skin Health Alliance.
International pharmaceutical company Galderma has increased its investment in research and innovation, initiating six new Phase III and IV US aesthetic clinical trials.
On September 28, guests were invited to breakfast at The Ivy Chelsea Garden in London to celebrate the launch of Chelsea Pharmacy Medical Clinic’s new high intensity focused ultrasound (HIFU) treatment.
Aesthetic practitioner Dr Ravi Jain, the owner of Riverbanks Wellness, held an anniversary event to celebrate the clinic’s 10th year in business on September 21.
Aesthetics reports on the British College of Aesthetics Medicine’s annual conference.